EMBO announces 64 newly elected members

Updated version issued on 4 August 2021, replacing the press release from 8 June 2021

8 June 2021 – EMBO is pleased to announce that 64 life scientists have been elected to its membership. The new EMBO Members and Associate Members join the community of more than 1,800 leading life scientists.

“I am delighted to welcome the new members into our organization and look forward to working with them,” says EMBO Director Maria Leptin. “An election to the EMBO Membership recognizes outstanding achievements in the life sciences. The new members will provide expertise and guidance that will help EMBO to further strengthen its initiatives.”

The 64 newly elected members reside in 21 countries: 55 new EMBO Members reside in member states of the EMBC, the intergovernmental organization that funds the major EMBO Programmes and activities. Nine new EMBO Associate Members reside in Argentina, Australia, India, Japan, and the USA. 28 of the new EMBO Members (44%) are women.

EMBO Members are actively involved in the organization. They serve on EMBO Council, Committees and Advisory Editorial Boards of EMBO Press journals, evaluate applications for EMBO funding, and mentor early-career scientists. Collectively, they can influence the direction of the life sciences in Europe and beyond.

New members are nominated and elected by the existing EMBO Membership; it is not possible to apply to become a member. One election is held each year. The new EMBO Members will be formally welcomed at the annual EMBO Members’ Meeting between 27 and 29 October 2021.

A directory of all EMBO Members, their affiliations and subject areas is available online: https://people.embo.org/

Selected statistics

• 64 life scientists have been elected to the EMBO Membership, 55 EMBO Members and nine Associate Members.
• The newly elected members reside in 21 countries.
• 28 of the new EMBO Members (44 %) are women.

New EMBO Members 2021

	Nathalie Q. Balaban	Hebrew University, Jerusalem, IL
	Alex Bateman	European Bioinformatics Institute (EMBL-EBI), Hinxton, UK
	Martin Beck	Max Planck Institute of Biophysics, Frankfurt am Main, DE
	Laurent Blanchoin	Interdisciplinary Research Institute of Grenoble, FR
	Adrian P. Bracken	Trinity College, Dublin, IE
	Inês Cardoso Pereira	Instituto de Tecnologia Química e Biológica António Xavier, Oeiras, PT
	Petr Cejka	Institute for Research in Biomedicine, Bellinzona, CH
	Jacqueline Cherfils	École Normale Supérieure, Paris, FR
	Rosa Cossart	Aix Marseille University, Inserm, INMED, Marseille, FR
	Peter J. Cullen	University of Bristol, UK
	Karin E. de Visser	Netherlands Cancer Institute, Amsterdam, and Oncode Institute, Utrecht, NL
	Miguel A. Del Pozo	Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, ES
	José Antonio Enríquez	Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, ES
	Tobias J. Erb	Max Planck Institute for Terrestrial Microbiology, Marburg, DE
	Jiří Fajkus	Masaryk University, Brno, CZ
	Rebecca C. Fitzgerald	MRC Cancer Cell Unit, Cambridge, UK
	Ervin Fodor	Sir William Dunn School, Oxford, UK
	Toni Gabaldón	Barcelona Supercomputing Centre (BSC-CNS) and Institute for Research in Biomedicine (IRB), Barcelona, ES
	Julie E. Gray	University of Sheffield, UK
	Takashi Hiiragi	EMBL, Heidelberg, DE
	Corinne Houart	King's College and Francis Crick Institute, London, UK
	Evelyn Houliston	Villefranche-sur-Mer Developmental Biology Laboratory, FR
	Matthew E. Hurles	Wellcome Sanger Institute, Cambridge, UK
	Matteo Iannacone	San Raffaele Scientific Institute & University, Milano, IT
	Kim B. Jensen	BRIC, University of Copenhagen, DK
	Robert J. Klose	University of Oxford, UK
	Alwin Köhler	Max Perutz Laboratories Vienna, AT
	Cris Kuhlemeier	University of Bern, CH
	Gianni Liti	IRCAN, Université Côte d'Azur, Nice, FR
	Robbie Loewith	University of Geneva, CH
	Ilaria Malanchi	Francis Crick Institute, London, UK
	John C. Marioni	EMBL-EBI and University of Cambridge, UK
	Elisa Martí	Instituto de Biología Molecular de Barcelona (IBMB), ES
	Massimiliano Mazzone	VIB – KU Leuven Center for Cancer Biology, BE
	F. Nina Papavasiliou	Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, DE
	Balázs Papp	Biological Research Centre and HCEMM, Szeged, HU
	Diego Pasini	European Institute of Oncology IRCCS and University of Milan, IT
	Andrea Pauli	IMP, Vienna, AT
	Rosa Rademakers	VIB-UA Center for Molecular Neurology, University of Antwerp, BE
	Markus Ralser	Charité - Universitätsmedizin, Berlin, DE and Francis Crick Institute, London, UK
	Juri Rappsilber	Technische Universität, Berlin, DE
	Oded Rechavi	Tel Aviv University, IL
	Beatriz Rico	Centre for Developmental Neurobiology, King’s College London, UK
	Uğur Şahin	Johannes-Gutenberg-Universität, Mainz, DE
	Liliane Schoofs	KU Leuven, BE
	Zofia Szweykowska-Kulińska	Adam Mickiewicz University, Poznan, PL
	Kristin Tessmar-Raible	Max Perutz Laboratories, University of Vienna, AT
	Özlem Türeci	BioNTech SE, Mainz, DE
	Wim Vermeulen	Erasmus University MC, Rotterdam, NL
	Raphael Voituriez	CNRS / Sorbonne Université, Paris, FR
	Eilika Weber-Ban	ETH Zurich, CH
	Karsten Weis	ETH Zurich, CH
	Karina B. Xavier	Instituto Gulbenkian de Ciência, Oeiras, PT
	Eleftheria Zeggini	Helmholtz Zentrum München, Neuherberg, DE
	Denise Zickler	Institute for Integrative Biology of the Cell (I2BC), University of Paris-Saclay, Orsay, FR

New EMBO Associate Members 2021

	Yasmine Belkaid	NIAID, NIH, Bethesda, US
	Hugo J. Bellen	Baylor College of Medicine, Houston, US
	María Fernanda Ceriani	Fundación Instituto Leloir, IIB-BA/CONICET, Buenos Aires, AR
	Mark Dawson	Peter MacCallum Cancer Centre, Melbourne, AU
	Akiko Iwasaki	Yale University School of Medicine/HHMI, New Haven, US
	Roop Mallik	Indian Institute of Technology, Mumbai, IN
	Keiko Sugimoto	RIKEN Center for Sustainable Resource Science, Yokohama, JP
	Masayo Takahashi	Kobe City Eye Hospital, Kobe, JP
	Leonard Zon	Boston Children's Hospital, US